This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cuschieri, A. Search for Related Content PubMed Articles by Cuschieri, A. Social Bookmarking                         What's this?

In Situ Ablation of Hepatic Tumors

Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland

The various technologies and approaches for in situ ablation of hepatic tumors are reviewed and the relative merits discussed. The reported experience, though limited, is encouraging but the technology is still maturing. At present in situ ablation ought to be restricted to patients with inoperable disease, unless patients are recruited into randomized trials comparing in situ ablation with hepatic surgical resection in specific patient groups. Emerging technologies such as gene therapy and electro/sonoporation will also impact on how we best manage patients with malignant hepatic tumors. It seems improbable that any one modality will prevail on efficacy, and a more likely scenario for future therapy may well be a combination multimodal approach tailored to the individual patient and the biological characteristics of the tumor. Copyright © 2001 by W.B. Saunders Company.

Key Words: In situ ablation • cryotherapy • thermal ablation • gene therapy • electroporation • sonoporation • liver tumors.

Surgical Innovation, Vol. 8, No. 1, 25-41 (2001)
DOI: 10.1177/155335060100800104


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?